Anchorage dependence is the requirement that most normal cells in your body must be physically attached to a surface, called the extracellular matrix, in order to survive, grow, and divide. If these cells lose that attachment, they stop multiplying and eventually die. This built-in safety mechanism keeps cells where they belong and prevents them from drifting to other parts of the body and growing out of control. When cancer cells lose this requirement, they gain the ability to spread.
How Cells Sense Attachment
Cells don’t just passively stick to their surroundings. They actively grip the extracellular matrix (a mesh of proteins like collagen, fibronectin, and laminin that surrounds cells in tissues) using surface receptors called integrins. The name “integrin” comes from the receptor’s role as an integral bridge between the outside scaffold and the cell’s internal skeleton. When integrins lock onto matrix proteins, they trigger a cascade of chemical signals inside the cell that essentially say “you’re in the right place, it’s safe to function.”
These signals travel through a few key relay proteins. Focal adhesion kinase (FAK) is one of the primary messengers: once integrins bind, FAK activates and passes the signal deeper into the cell. From there, pathways controlling growth, survival, and movement switch on. Importantly, the attachment has to happen through the correct integrin. Research shows that cells expressing a specific integrin called α5β1, which binds fibronectin, survive for extended periods on fibronectin surfaces, while cells using an alternative fibronectin receptor die under the same conditions. No other integrin tested could substitute. The reason appears to be that α5β1 boosts production of an anti-death protein that keeps the cell alive. Other cell types rely on different integrins: blood vessel cells depend on αvβ3, and epithelial cells depend on integrins that bind laminin.
Why Attachment Controls Cell Division
Anchorage dependence is tightly wired into the cell cycle. For a cell to copy its DNA and divide, it must pass through a checkpoint between the first growth phase (G1) and the DNA-replication phase (S). Without integrin-mediated attachment, cells stall at this checkpoint. The attachment signals help produce specific proteins (cyclins) that push the cell past the checkpoint while simultaneously reducing levels of proteins that act as brakes on division. Without those signals, the brakes stay on, and the cell simply stops cycling.
This means that even if a cell is bathed in growth factors telling it to divide, it won’t proceed unless it’s also anchored. Growth factor signals and attachment signals work together like a two-key system: both are required to unlock cell division.
What Happens When Cells Detach
When an anchorage-dependent cell loses contact with the extracellular matrix, it doesn’t just stop dividing. It enters a hostile environment marked by several simultaneous stresses: the loss of growth signals from the matrix, changes in mechanical forces on the cell, reorganization of its internal skeleton, reduced ability to take in nutrients, lower energy production, and a surge in damaging reactive oxygen species.
Under these conditions, the cell typically undergoes a specific form of programmed death called anoikis (from the Greek word for “homelessness”). Anoikis activates the same self-destruction machinery used in other forms of programmed cell death, involving enzymes called caspases and signals from the cell’s internal death-or-survival regulators. This process is essential for tissue maintenance. It prevents, for example, a gut lining cell that sloughs off from surviving in the bloodstream and settling somewhere it doesn’t belong.
Not every detached cell dies through anoikis, though. Research has identified at least four fates for detached cells: anoikis, autophagy (where the cell digests its own components), entosis (where one cell engulfs another), and simple cell cycle arrest where the cell goes dormant without immediately dying.
Which Cells Don’t Need Anchorage
Blood cells are the most obvious exception. White blood cells, red blood cells, and platelets all circulate freely without any matrix attachment. This makes biological sense: their entire job requires moving through the bloodstream and, in the case of immune cells, migrating into tissues wherever they’re needed. These cells evolved to survive and function without anchorage signals.
Some immune cells do use integrins at certain stages. T cells, for instance, show anchorage dependence when they’re being activated to divide. Prolonged integrin-dependent contact is required for them to produce the growth signals that drive their multiplication. So even cells we think of as “free-floating” can require temporary anchorage for specific functions.
Anchorage Independence in Cancer
One of the defining features of cancer cells is their ability to survive and grow without being attached to the extracellular matrix. This trait, called anchorage independence, is considered a hallmark of malignant transformation. It’s what allows cancer cells to detach from the original tumor, survive the journey through the bloodstream or lymphatic system, and establish new tumors in distant organs.
Cancer cells achieve this through several molecular changes. Many activate the YAP/TEAD signaling pathway, which is normally switched off when cells detach. In cancer, this pathway stays active and actually increases the production of integrins and matrix proteins, essentially letting the cell generate its own survival signals. Some cancers also disable anoikis by overproducing survival proteins or silencing the death signals that would normally destroy a floating cell. Fibronectin and its receptors act as tumor suppressors under normal circumstances: reducing their function promotes more aggressive cell behavior, though losing them entirely is actually a disadvantage for tumor cells, since they still need some matrix interaction to thrive.
Testing Anchorage Independence in the Lab
Researchers use a classic experiment called the soft agar colony formation assay to measure whether cells have become anchorage-independent. Cells are suspended in a gel-like layer of soft agar, which prevents them from attaching to a hard surface. Normal cells won’t grow under these conditions. Cancer cells or cells that have undergone malignant transformation will form visible colonies within the gel over a period of weeks. This assay, developed in the late 1970s, remains one of the standard methods for detecting the tumorigenic potential of cells and for evaluating whether anti-cancer treatments can suppress this ability.
How Lab-Grown Cells Are Kept Anchored
Because most human cells are anchorage-dependent, growing them in a lab requires providing a surface they can attach to. Standard cell culture flasks are made of treated plastic that carries a slight charge to promote adhesion, but many cell types need more than that. Coating the surface with extracellular matrix proteins dramatically improves attachment and growth. Type I collagen is one of the most commonly used coatings. Studies show that human fibroblasts cultured on collagen-coated surfaces attach faster and grow better than those on uncoated plastic. The same holds for skin cells (keratinocytes) and cartilage cells (chondrocytes). Other coatings include fibronectin, laminin, aggrecan, and commercial mixtures of basement membrane proteins. The choice depends on the cell type, since different cells express different integrins and therefore need different matrix proteins to latch onto.
Some researchers also modify surfaces through chemical treatments like silanization or ozone oxidation to change their properties. Amino-silanized and collagen-coated porous silicon both promote cell attachment effectively, while surfaces coated with water-attracting polymers repel cells. These details matter in tissue engineering, wound healing research, and any application where cells need to be grown outside the body on artificial scaffolds.